Fierce Healthcare February 21, 2018
If Medicare Advantage encounter data are good enough to be used for calculating payments to insurers, it should be good enough to provide to researchers, argues a new JAMA Viewpoint piece.
Despite concerns about the quality of Medicare Advantage encounter data, it’s long past time to make that information available to researchers who want to study the ever-growing privatized Medicare program.
That’s the argument of a new Viewpoint piece published by the Journal of the American Medical Association, which is largely a reaction to the Centers for Medicare & Medicaid Services’ decision last June to cancel the release of data on MA enrollees’ diagnoses and the services they received.
CMS said at the time that it made that decision...